Sign inJoin waitlistJoin the waitlist

NC

Nai-Kong Cheung

Enid A. Haupt Chair in Pediatric Oncology, Pediatrics · New York Presbyterian Hospital

Credentials: · · ·

History

New York Presbyterian Hospital
Present
CUNY City College
Present

Research

Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
The Lancet Oncology · 2018 · 226 citations
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells
Nature · 2020 · 200 citations
Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma
Review · Journal of Clinical Oncology · 1991 · First of 2 authors · 185 citations

SM
Shakeel Modak
25 papers
BK
Brian Kushner
24 papers
SL
Steven Larson
22 papers
KK
Kim Kramer
21 papers
EB
Ellen Basu
17 papers
SR
Stephen Roberts
16 papers
SW
Suzanne Wolden
12 papers
MQ
Michael La Quaglia
10 papers
Neeta Pandit-Taskar
10 papers · 2 as a fellow
JC
Jorge Carrasquillo
7 papers
Dana Casey
6 papers · 5 as a resident
Ira Dunkel
6 papers

Grants

Systemic Theranostic 203Pb/212Pb Alpha-Radioimmunotherapy for Advanced Colorectal Cancer
National Cancer Institute · R01
PI · $724.3K · Weill Medical Coll of Cornell Univ
2026–2031
Dual Targeting of Tumoral Microenvironment and Tumoral Cells by Blocking the IL-33/ST2 Pathway
National Cancer Institute · U01
PI · $4.3M · Medical University of South Carolina
2018–2024
Targeting Neuroblastoma with Armed T Cells
National Cancer Institute · R01
PI · $3.9M · University of Virginia
2014–2021
Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients with High-
National Cancer Institute · R21
Contact PI · $752.4K · Sloan-Kettering Inst Can Research
2011–2013

Clinical trials

Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2006–2015
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Principal investigator · Terminated · Phase 1
Memorial Sloan Kettering Cancer Center
2004–2008
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
2000–2026
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Study chair · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2004